LAWMAKERS INTRODUCE FEDERAL LEGISLATION TO PREVENT ORGAN TRANSPLANT DISCRIMINATION  

FOR IMMEDIATE RELEASE    NDSS MEDIA CONTACT:  Michelle Sagan  media@ndss.org  301-728-0447    LAWMAKERS INTRODUCE FEDERAL LEGISLATION TO PREVENT ORGAN TRANSPLANT DISCRIMINATION     Washington, D.C. (December 2, 2021) - The National Down Syndrome Society (NDSS), the leading human rights organization for all individuals with Down syndrome, applauds the introduction of the Senate companion to the Charlotte Woodward Organ Transplant Discrimination Prevention Act (H.R. 1235/ S.3301) to prohibit […]


NDSS Statement About Zac Stacy Video

November 18, 2021 The National Down Syndrome Society (NDSS) is horrified by the video of former NFL football player Zac Stacy attacking the mother of his child. NDSS last partnered with him in 2019 to conduct a football clinic for individuals with Down syndrome and their siblings. We do not have a current partnership with […]


National Down Syndrome Society Announces New Board of Directors Leadership and Members 

FOR IMMEDIATE RELEASE   NDSS Contact:   Michelle Sagan media@ndss.org 301-728-0447 National Down Syndrome Society Announces New Board of Directors Leadership and Members    New York, NY (Sept. 24, 2021) – The National Down Syndrome Society (NDSS), the leading human rights organization for all individuals with Down syndrome, is pleased to introduce their newly elected board chairwoman, […]


NDSS hosts 340 Mile Run from Los Angeles, CA to Las Vegas, NV

NEW YORK, NY (August 30, 2021) – The National Down Syndrome Society (NDSS), the leading human rights organization for all individuals with Down syndrome, is preparing to take on a new kind of running challenge this weekend. Run for 3.21 LALV is a 50+ hour relay that will cover 340 miles from Los Angeles to Las Vegas through the California desert. Beginning on Friday, […]


NDSS, LuMind IDSC and NTG CMS Response Letter

The National Down Syndrome Society (NDSS) is joined by LuMind IDSC and The National Task Group on Intellectual Disabilities and Dementia Practices (NTG) in submitting comments to federal Medicaid and Medicare regulators, asking them to give thought to the consequences for people with Down syndrome as this new class of Alzheimer’s disease drugs is considered […]